GlassScriptPhysician profile
Anna O Likhacheva
NPI 1689950297
$7,741.39
in general payments reported to CMS, 2019-2025
5 companies · $3,021 in 2025
The $3,021 reported for 2025 was more than what 93% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,125 · 2023: $1,780 · 2024: $815 · 2025: $3,021.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,115 · Consulting Fee: $1,450 · Food and Beverage: $1,052 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,114.75 |
| Consulting Fee | $1,450.00 |
| Food and Beverage | $1,051.64 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $5,114.00 | 2021-2025 | Bravos Afterloader System, Vitesse, Varian Ethos Treatment Planning |
| Palette Life Sciences, INC. | $1,687.80 | 2023 | |
| Teleflex LLC | $799.81 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2021 | |
| Bioprotect Medical, INC. | $14.78 | 2024 | Bioprotect Balloon Implant System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Likhacheva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.